Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David B Resnik

Showing results (71-80 of 241) with videos related to

Pageof 25
Sort By:
The American Journal of Bioethics : AJOB|September 20, 2008
Hidden sources of private industry fundingDavid B Resnik
Contemporary Clinical Trials|November 4, 2008
Do informed consent documents matter?David B Resnik
Science and Engineering Ethics|November 14, 2008
What is "dual use" research? A response to Miller and SelgelidDavid B Resnik
Accountability in Research|September 13, 2007
Intentional exposure studies of environmental agents on human subjects: assessing benefits and risksDavid B Resnik
The Hastings Center Report|April 11, 2021
Public Engagement and the Social Risks of ScienceDavid B Resnik
Monitor (Associates of Clinical Pharmacology)|April 17, 2015
Postmarketing Research and Surveillance: Issues and ChallengesDavid B Resnik
Health Policy (Amsterdam, Netherlands)|July 10, 2003
Are DNA patents bad for medicine?David B Resnik
Accountability in Research|October 21, 2011
Disclosure of individualized research results: a precautionary approachDavid B Resnik
Accountability in Research|January 17, 2019
Is it time to revise the definition of research misconduct?David B Resnik
The Hastings Center Report|December 27, 2018
Difficulties with Applying a Strong Social Value Requirement to Clinical ResearchDavid B Resnik
Pageof 25

Showing results (71-80 of 241) with videos related to

Sort By:
Pageof 25
The American Journal of Bioethics : AJOB|September 20, 2008
Hidden sources of private industry fundingDavid B Resnik
Contemporary Clinical Trials|November 4, 2008
Do informed consent documents matter?David B Resnik
Science and Engineering Ethics|November 14, 2008
What is "dual use" research? A response to Miller and SelgelidDavid B Resnik
Accountability in Research|September 13, 2007
Intentional exposure studies of environmental agents on human subjects: assessing benefits and risksDavid B Resnik
The Hastings Center Report|April 11, 2021
Public Engagement and the Social Risks of ScienceDavid B Resnik
Monitor (Associates of Clinical Pharmacology)|April 17, 2015
Postmarketing Research and Surveillance: Issues and ChallengesDavid B Resnik
Health Policy (Amsterdam, Netherlands)|July 10, 2003
Are DNA patents bad for medicine?David B Resnik
Accountability in Research|October 21, 2011
Disclosure of individualized research results: a precautionary approachDavid B Resnik
Accountability in Research|January 17, 2019
Is it time to revise the definition of research misconduct?David B Resnik
The Hastings Center Report|December 27, 2018
Difficulties with Applying a Strong Social Value Requirement to Clinical ResearchDavid B Resnik
Pageof 25